Literature DB >> 23436032

Prevention of diabetes-induced cardiovascular complications upon treatment with antioxidants.

Yan-Jun Xu1, Paramjit S Tappia, Nirankar S Neki, Naranjan S Dhalla.   

Abstract

Oxidative stress is considered to play an important role in the pathogenesis of diabetes-induced cardiovascular disease (CVD), which is invariably associated with abnormal blood lipid profile, insulin resistance and metabolic syndrome. Stress, smoking, high saturated fat intake as well as low fruit and vegetable intakes have been shown to increase oxidative stress and hyperlipidemia, which increase the predisposition of diabetic subjects to atherosclerosis, stroke and coronary heart disease. The oxidation of low-density lipoprotein by oxidative stress is essential for the development of atherosclerosis, and the reduction in oxidative stress as well as blood glucose and cholesterol is considered critical for the prevention of diabetes-induced CVD. Although epidemiological studies have demonstrated that vitamin C and vitamin E decrease the incidence of coronary heart disease, different clinical trials have failed to support the beneficial effect of these antioxidants. Nonetheless, it has been suggested that natural forms of these vitamins may be more efficacious than synthetic vitamins, and this may explain the inconsistencies in results. Antioxidants, N-acetyl-L-cysteine and resveratrol, have also been shown to attenuate the diabetes-induced cardiovascular complications. It has been indicated that the antioxidant therapy may be effective in a prevention strategy rather than as a treatment for CVD. The evidence presented here supports the view that cardiovascular complications in diabetes may be induced by oxidative stress and appropriate antioxidant therapy may be promising for attenuating the progression of diabetes-induced CVD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23436032     DOI: 10.1007/s10741-013-9379-6

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  76 in total

Review 1.  Why have antioxidants failed in clinical trials?

Authors:  Steven R Steinhubl
Journal:  Am J Cardiol       Date:  2008-05-22       Impact factor: 2.778

Review 2.  Resveratrol and diabetic cardiac function: focus on recent in vitro and in vivo studies.

Authors:  Belma Turan; Erkan Tuncay; Guy Vassort
Journal:  J Bioenerg Biomembr       Date:  2012-04       Impact factor: 2.945

3.  Modified resveratrol Longevinex improves endothelial function in adults with metabolic syndrome receiving standard treatment.

Authors:  Keisuke Fujitaka; Hajime Otani; Fusakazu Jo; Hiromi Jo; Emiko Nomura; Masayoshi Iwasaki; Mitsushige Nishikawa; Toshiji Iwasaka; Dipak K Das
Journal:  Nutr Res       Date:  2011-11       Impact factor: 3.315

4.  Antioxidant vitamins and coronary heart disease.

Authors:  D Steinberg
Journal:  N Engl J Med       Date:  1993-05-20       Impact factor: 91.245

5.  Hyperketonemia can increase lipid peroxidation and lower glutathione levels in human erythrocytes in vitro and in type 1 diabetic patients.

Authors:  S K Jain; R McVie
Journal:  Diabetes       Date:  1999-09       Impact factor: 9.461

6.  Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus.

Authors:  Jayesh Kumar Bhatt; Sabin Thomas; Moola Joghee Nanjan
Journal:  Nutr Res       Date:  2012-07-27       Impact factor: 3.315

7.  The concentrations of soluble vascular cell adhesion molecule-1 and lipids are independently associated with venous thromboembolism.

Authors:  Angel José González-Ordóñez; José-Manuel Fernández-Carreira; Carmen Rosa Fernández-Alvarez; Rafael Venta Obaya; Marìa Dolores Macías-Robles; Alvaro González-Franco; Maria Ana Arias Garcìa
Journal:  Haematologica       Date:  2003-09       Impact factor: 9.941

8.  Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials.

Authors:  Sandra M Swain; Fredrick S Whaley; Michael S Ewer
Journal:  Cancer       Date:  2003-06-01       Impact factor: 6.860

Review 9.  Congestive heart failure in the diabetic.

Authors:  T J Regan
Journal:  Annu Rev Med       Date:  1983       Impact factor: 13.739

10.  Supplementation of vitamin C reduces blood glucose and improves glycosylated hemoglobin in type 2 diabetes mellitus: a randomized, double-blind study.

Authors:  Ganesh N Dakhale; Harshal V Chaudhari; Meena Shrivastava
Journal:  Adv Pharmacol Sci       Date:  2011-12-28
View more
  36 in total

Review 1.  Programming apoptosis and autophagy with novel approaches for diabetes mellitus.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2015       Impact factor: 1.990

Review 2.  Erythropoietin and diabetes mellitus.

Authors:  Kenneth Maiese
Journal:  World J Diabetes       Date:  2015-10-25

3.  mTOR: Driving apoptosis and autophagy for neurocardiac complications of diabetes mellitus.

Authors:  Kenneth Maiese
Journal:  World J Diabetes       Date:  2015-03-15

Review 4.  Erythropoietin and mTOR: A "One-Two Punch" for Aging-Related Disorders Accompanied by Enhanced Life Expectancy.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2016       Impact factor: 1.990

5.  Sirtuins: Developing Innovative Treatments for Aged-Related Memory Loss and Alzheimer's Disease.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2018       Impact factor: 1.990

Review 6.  Novel Treatment Strategies for the Nervous System: Circadian Clock Genes, Non-coding RNAs, and Forkhead Transcription Factors.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2018       Impact factor: 1.990

Review 7.  FoxO Transcription Factors and Regenerative Pathways in Diabetes Mellitus.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2015       Impact factor: 1.990

8.  Dysregulation of metabolic flexibility: The impact of mTOR on autophagy in neurodegenerative disease.

Authors:  Kenneth Maiese
Journal:  Int Rev Neurobiol       Date:  2020-08-11       Impact factor: 3.230

Review 9.  Cognitive impairment with diabetes mellitus and metabolic disease: innovative insights with the mechanistic target of rapamycin and circadian clock gene pathways.

Authors:  Kenneth Maiese
Journal:  Expert Rev Clin Pharmacol       Date:  2020-01-03       Impact factor: 5.045

Review 10.  Hyperglycemia-induced cardiac contractile dysfunction in the diabetic heart.

Authors:  Raphael M Singh; Tahreem Waqar; Frank C Howarth; Ernest Adeghate; Keshore Bidasee; Jaipaul Singh
Journal:  Heart Fail Rev       Date:  2018-01       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.